CIK 0001124105 · Accelerated filer<br>Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562020050
- Phone
- (858) 284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- EFFECT Other Notice of Effectiveness
- SC 13G Stake Amended Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- SC 13G Stake Amended Statement of Ownership
- S-3 Offering Registration Statement
- SC 13G/A Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
- 8-K Event Executive or director change
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Other events
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 8-K Event Other events
Page 37 of 81 · 1,604 filings